Borrowings (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Aug. 15, 2022 |
|
| Borrowings | |||
| Aggregate shares issued upon exercise of warrants | 1 | ||
| Interest expense from amortization of debt discounts | $ 1,260,000 | $ 850,000 | |
| Maxim Group LLC | |||
| Borrowings | |||
| Aggregate shares issued upon exercise of warrants | 13 | ||
| Warrants exercise price (in $ per share) | $ 14,955 | ||
| Convertible Promissory Note | |||
| Borrowings | |||
| Interest expense from amortization of debt discounts | $ 1,260,000 | $ 737,000 | |
| X | ||||||||||
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|